Posts Tagged: Warren Chan
Another cohort of outstanding students from across the Faculty have been presented with U of T Student Leadership Awards.
Two BME students receives Dorrington Graduate Award.
Throughout the pandemic, our students are working hard to advance scientific knowledge. Check out our new video: "Day in the life of a graduate student", featuring BME/Chemistry PhD student Johnny Zhang.
Researchers at the University of Toronto (Institute of Biomedical Engineering, Department of Chemistry, Donnelly Centre for Biomolecular Research) in collaboration with Sunnybrook Health Sciences Centre, Public Health Ontario, and Mt. Sinai Hospital have engineered a diagnostic test with a smartphone reader to surveil and track COVID-19 patients.
2020 Yip Awards Recognize Early Graduate Research in Cross-Disciplinary Biomedicine
U of T Engineering researchers have discovered a dose threshold that greatly increases the delivery of cancer-fighting drugs into a tumour.
Syed is the latest winner of the Donnelly Centre Research Thesis Prize, awarded annually for the best doctoral research completed at the Centre. An engineer by training, he studied how tiny nano-scale particles travel through the body to deliver drugs directly to tumours under the supervision of Warren Chan, a principal investigator at the Centre and the director of U of T’s Institute for Biomaterials and Biomedical Engineering.
While most people are sheltering at home, for a team led by Professor Warren Chan it’s business as usual as they continue to develop an automated, more sensitive and rapid test for COVID-19 to help curb the pandemic.
Prof. Warren Chan, Dr. Samira Mubareka, Dr. Jonathan Gubbay and their trainees have summarized current diagnostic tools for detecting and surveilling COVID-19 in the journal ACS Nano. This article aims to guide researchers in developing COVID19 diagnostics by discussing current and emerging diagnostic tools.
Most Engineered Nanoparticles Enter Tumours Through Cells, Not Between them, U of T Researchers Find
University of Toronto researchers have discovered that an active rather than passive process dictates which nanoparticles enter solid tumours, upending decades of thinking in the field of cancer nanomedicine and pointing toward more effective nanotherapies.
Showing 11 - 20 of 36 results